Cafepharma Today

March 24 2025 - Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
23andMe files for bankruptcy, Anne Wojcicki steps down as CEO
Biogen plots 2028 headquarters shift to new 'innovation hub' in Cambridge
Pharmaceutical supply chain headed for $5.3B valuation
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

King Pharma a Hold, Pre-Acquisition
Yahoo/Zacks.com
Wednesday, August 27, 2008 - 4:26pm
tags:
Grim Reaper Hurts Cell Genesys
Forbes
Wednesday, August 27, 2008 - 4:25pm
tags:
Another Storm Brewing For Vytorin
Forbes
Wednesday, August 27, 2008 - 4:23pm
tags:
Amylin, Lilly: Another Case of a Panic Driven Sell-Off
Seeking Alpha
Wednesday, August 27, 2008 - 4:20pm
tags:
Bad News Byetta
Forbes
Wednesday, August 27, 2008 - 4:19pm
tags:
NexMed shares nosedive as partner Novartis nixes plan to file for approval of treatment
Yahoo/AP
Wednesday, August 27, 2008 - 4:17pm
tags:
Bristol-Myers shares dip on failed drug study
Yahoo/AP
Wednesday, August 27, 2008 - 4:16pm
tags:
Teva Tells It Like It Is
Motley Fool
Wednesday, August 27, 2008 - 4:14pm
tags:
Pills and Politics: The normally GOP-friendly drug industry now favors Obama
Slate
Wednesday, August 27, 2008 - 12:03pm
tags:
When it rains risk it pours; within a 12-hour period five biopharma companies revealed negative drug news that is sending their stocks lower
CNBC
Wednesday, August 27, 2008 - 12:00pm
tags:
Drug maker Schering-Plough wins EU OK to sell animal medicines to rival Pfizer
Yahoo/AP
Wednesday, August 27, 2008 - 11:56am
tags:
Will hostile takeovers become the norm for drugmakers?
Bizmology
Wednesday, August 27, 2008 - 10:15am
tags:
Amylin Tumbles After Four More Patients Die While Using Byetta
Bloomberg
Wednesday, August 27, 2008 - 10:01am
tags:
The Early Edge: Amylin Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly, and Pfizer
Schaeffer's Research
Wednesday, August 27, 2008 - 10:00am
tags:
A Failure Makes Bristol’s Deal With Pfizer Look Smart
WSJ Online
Wednesday, August 27, 2008 - 8:48am
tags:
Pain Therapeutics and King Pharmaceuticals Develop a New Abuse-Resistant Prescription Pain Medication
Trading Markets
Wednesday, August 27, 2008 - 8:41am
tags:
AstraZeneca Adds an Electronic Component to Physician Mailers
PharmExec
Wednesday, August 27, 2008 - 8:12am
tags:
New FDA Rules Say When Pharma Can Act Alone
PharmExec
Wednesday, August 27, 2008 - 8:10am
tags:
Novavax Moves Closer to Licensing Bird Flu Vaccine
Washington Post, DC
Wednesday, August 27, 2008 - 7:26am
tags:
Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer
Yahoo
Wednesday, August 27, 2008 - 7:24am
tags:

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

Informa Connect’s Life Sciences Pricing & Contracting USA
Drug Channels
Metamorphine, An Unwelcome Product
In the Pipeline
The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization
Drug Channels
A New Type of Antifungal
In the Pipeline
The Continuing Crisis, Part IX: Inside the NIH Now
In the Pipeline
NOW AVAILABLE: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
How Much Does Math Help Chemistry Students?
In the Pipeline
The Continuing Crisis, Part VIII: mRNA Vaccines Under Attack
In the Pipeline
Direct-to-Consumer Models: Why They’re Expanding and Where They Deliver the Most Impact
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.